1.50 USD
↘ 0.09 (5.38%)LIVE (AS OF 03:21 PM EDT)
RenovoRx, Inc. Common Stock
RNXTNASDAQ • USD
Market: OPEN
RenovoRx, Inc. Common Stock (RNXT) is currently trading at $1.50. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$1.58
High?$1.60
Low?$1.44
Prev. Close?$1.58
Volume?522.2K
Avg. Volume?1.2M
VWAP?$1.50
Rel. Volume?0.44x
Bid / Ask
Bid?$1.49 × 1.1K
Ask?$1.50 × 2.8K
Spread?$0.01
Midpoint?$1.50
Valuation & Ratios
Market Cap?71.3M
Shares Out?45.1M
Float?43.4M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?7.94
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Employees
17
Market Cap
71.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-26
Address
2570 W. EL CAMINO REAL, STE. 320,
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?50
Short Sent.?60
Piotroski F-Score?3/9Weak
Altman Z-Score?6.10Safe
Confidence?48%Low
Short InterestLow
Short % of Float?1.55%Low
Short Interest?673.6K
Days to Cover?1.0
Free Float43.4M
Avg Daily Volume2.1M
Settlement Date2026-09-15
Financial Health
Current Ratio?5.74Strong
Quick Ratio?5.53Strong
Cash Ratio?5.03Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.94FAIR▾
Peers100
S&P24
P/S?36.09HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?31.29HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-136.8%WEAK▾
S&P3
ROA?-107.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11937000
Enterprise Value?$61.8M
Fundamentals ratios updated end of day